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The European Commission (EC) has missed a unique opportunity to develop a regulatory 
system that sets new standards in the protection against endocrine-disrupting chemicals. The 
proposed amendments to the European Union (EU) pesticide law and the criteria for the 
identification of endocrine disruptors that the EC published on June 15, 2016, after a delay of 
almost 3 years,1 ensure that hardly any endocrine disruptors used as pesticides will be barred 
from commerce. 
EU legislation requires that all chemicals used as pesticides and biocides are approved through a 
riskassessment procedure that estimates a safe level of exposure. However, by a hazard-based 
exclusion clause, substances identified as carcinogens, mutagens, reproductive toxicants, and 
endocrine disruptors do not enter this complex risk-assessment process. To minimise exposure 
to these hazardous substances via food, these substances are generally refused approval, but 
specific derogations (exemptions) exist. For pesticides, approval can still be granted if exposure 
is negligible. Since there is no exposure via food, this rule is somewhat relaxed for biocides, for 
which approval can be given if the risk is judged negligible. 
In violation of the hazard-based exclusion philosophy of the pesticide law, the EC has now 
proposed an amendment that extends the relaxation for biocides to endocrine disruptors in 
pesticides. These substances will be treated less restrictively than carcinogens, mutagens, and 
reproductive toxicants, and exactly like other pesticide substances that have less hazardous 
properties. In practice, this means that exposures via food will continue to occur. This outcome 
is of concern because some pesticides can produce irreversible endocrine-disrupting effects. An 
example is the organophosphate chlorpyrifos, which can affect thyroid hormone 
concentrations,2 which in pregnant women can significantly affect children’s IQ and brain 
structure.3 Similarly, some widely used pesticides can antagonise the androgen receptor and 
suppress prostaglandin synthesis, with potentially irreversible consequences for male sexual 
development in fetal life.4 
Previously, the EC had listed four options to define regulatory criteria for endocrine disruptors, 
of which two (labelled 2 and 3) rely on the WHO definition of endocrine disrupters. Earlier, we 
favoured option 3, which allows differentiation between known, presumed, and suspected 
endocrine disruptors.5 The EC now supports option 2, with a single category for endocrine 
disrupters, but with a twist that will raise the degree of proof required for a chemical to be 
classified as an endocrine disrupter. The proposed option 2 differs from how carcinogens, 
mutagens, and reproductive toxicants are currently categorised in EU law. The strictest hazard 
category 1 differentiates between known (1a) and presumed (1b) carcinogens, mutagens, or 
reproductive toxicants. The evidence required for category 1a is normally based on human 
studies, whereas category 1b relies on data from animal studies, but categorisation as 1a or 1b 
triggers the same regulatory restrictions. The draft endocrine disrupter criteria depart from this 
distinction and replace the requirement for a presumption with the much stronger demand that 
a chemical must be known to cause an endocrine- disrupting adverse effect relevant for human 
health. 
Should these proposals be adopted, many endocrine disrupters with human exposure will 
escape identification, thus eroding the high level of protection enshrined in the EU pesticide and 
biocide laws, and violating the demand for scientifically- based endocrine disrupter criteria. 
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